Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries presents second quarter 2023 financial results and operational performance, covering generic pharmaceuticals, innovative medicines including AUSTEDO and COPAXONE, and biosimilar portfolio development. The presentation addresses competitive positioning, pipeline strategies, and risk factors affecting the company's outlook in a dynamic pharmaceutical market.
earnings
37 Pages
earnings
19 Pages
Brady Corporation
Bumrungrad Hospital 1Q 2023 Earnings Analyst Presentation
earningsearnings
42 Pages
Bumrungrad Hospital Public Company Limited
Dialog Semiconductor Q3 2016 Earnings Results
earningsearnings
26 Pages
Dialog Semiconductor